QZQilin Zhai

Qilin Zhai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qilin Zhai has a total of 32 co-authors. Here are the top co-authors by number of shared publications:

  • Dacheng Bu

    Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, P.R. China

    2 shared publications
  • Hongyan Jing

    Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, P.R. China

    2 shared publications
  • Jican Liu

    Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, P.R. China

    2 shared publications
  • Jing Liu

    Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, P.R. China

    2 shared publications
  • Junxia Yao

    Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, P.R. China

    2 shared publications
  • Kui Lu

    Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai, P.R. China

    2 shared publications

Latest Publications

  • Open Access

    The predictive value of CD4, CD8, and C—reactive protein in the prognosis of schistosomal and non-schistosomal colorectal cancer

    by Meihong Cheng, Hongyan Jing, Dacheng Bu, Jing Liu, Kui Lu, Jican Liu, Yanchao Xu, Ting Zhu, Yingyong Hou, Junxia Yao, et al.

    Background: Although schistosomiasis has been basically eliminated, it has not been completely extinction in China and occasional outbreaks occur in Europe in recent years. The relationship between inflammation caused by Schistosoma japonicum and colorectal cancer (CRC) is still obscure, and the inflammation based prognostic systems of schistosomal colorectal (SCRC) has rarely been reported. Aim: To explore the different roles of tumor infiltrating lymphocytes (TILs) and C-reactive protein (CRP) in SCRC and in Non-schistosomal CRC (NSCRC), providing a possible predictive system to evaluate outcomes and to improve the risk stratification for CRC patients, especially for CRC patients with schistosomiasis. Methods: Three hundred fifty-one CRC tumors were evaluated for density of CD4 + , CD8 + T cells and CRP in intratumoral and stromal compartments by immunohistochemical using tissue microarray. Results: There were no association between TILs and CRP and schistosomiasis. Multivariate analysis identified stromal CD4 (sCD4) (p = 0.038), intratumoral CD8 (iCD8) (p = 0.003), schistosomiasis (p = 0.045) as independent prognostic factors for overall survival (OS) in the whole cohort; and sCD4 (p = 0.006) and iCD8 (p = 0.020) were independent prognostic factors for OS in the NSCRC and SCRC set, respectively. Besides, we found that there were no differences of TILs and CRP, which were distributed in different areas of tumor tissue, between CRC patients with and without schistosomiasis. Conclusion: The results remind us that different subtypes of TILs have distinguished biological behavior and prognosis value in the immune microenvironment of NSCRC and SCRC patients. Meanwhile, the findings require us to stratify patients with schistosomiasis and this might facilitate patient counseling and management.


  • Open Access

    The distinguishing Predictive Value of CD4, CD8, and C - reactive protein in the Prognosis of Schistosomal and Non-Schistosomal Colorectal Cancer

    by Qilin Zhai, Hongyan Jing, Dacheng Bu, Jing Liu, Kui Lu, Jican Liu, Yanchao Xu, Ting Zhu, Yingyong Hou, Junxia Yao, et al.

    Background: The comparison of inflammation related factors between SCRC and non-schistosomal colorectal cancer (NSCRC) was not reported in previous literatures, and the inflammation based prognostic systems of SCRC were also unknown.Aim: To explore the different roles of tumor infiltrating lymphocytes (TILs) and CRP in SCRC and in NSCRC, providing a possible predictive system to evaluate outcomes and to improve the risk stratification for CRC patients, especially for patients with schistosomiasis.Methods: 351 CRC tumours were evaluated for density of CD4+, CD8+ T cells and CRP in intratumoural and stromal compartments by immunohistochemical using tissue microarray.Results: There were no association between TILs and CRP and schistosomiasis. Multivariate analysis identified sCD4 (p=0.038), iCD8 (p=0.003), schistosomiasis (p=0.045) as independent prognostic factors for overall survival (OS) in the whole cohort; and sCD4 (p=0.006) and iCD8 (p=0.020) were independent prognostic factors for OS in the NSCRC and SCRC set, respectively. Besides, we found that there were no differences of TILs and CRP, which were distributed in different areas of tumor tissue, between CRC patients with and without schistosomiasis.Conclusion: TILs in different tumor areas has distinguished predictive value in CRC patients with schistosomiasis and without schistosomiasis, reflecting variable tumor immunoenvironments in them.

  • Open Access

    Urolithin a attenuates IL-1β-induced inflammatory responses and cartilage degradation via inhibiting the MAPK/NF-κB signaling pathways in rat articular chondrocytes

    by Sheng-Long Ding, Zhi-Ying Pang, Xue-Mei Chen, Zheng Li, Xin-Xin Liu, Qi-Lin Zhai, Jun-Ming Huang, Zhi-Yong Ruan

    Background: Osteoarthritis (OA) is characterized by inflammation and extracellular matrix (ECM) degradation and is one of the most common chronic degenerative joint diseases that causes pain and disability in adults. Urolithin A (UA) has been widely reported for its anti-inflammatory properties in several chronic diseases. However, the effects of UA on OA remain unclear. The aim of the current study was to investigate the anti-inflammatory effects and mechanism of UA in interleukin-1β (IL-1β)-induced chondrocytes. Results: No marked UA cytotoxicity was noted, and UA protected cartilage from damage following IL-1β stimulation in micromasses. Moreover, UA promoted the expression of anabolic factors including Sox-9, Collagen II, and Aggrecan while inhibiting the expression of catabolic factors such as matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4) in rat chondrocytes. Protective effects of UA were also observed in ex vivo organ culture of articular cartilage. Mechanistically, IL-1β significantly activated and upregulated the expression of p-ERK 1/2, p-JNK, p-P38, and p-P65, while UA protected chondrocytes against IL-1β-induced injury by activating the mitogen-activated kinase (MAPK)/nuclear factor-κB (NF-κB) signaling pathways. Conclusion: Our results provide the evidence that UA could attenuate IL-1β-induced cell injury in chondrocytes via its anti-inflammatory action. UA may be a promising therapeutic agent in the treatment of OA.


  • Updated Three-Column Concept in surgical treatment for tibial plateau fractures – A prospective cohort study of 287 patients

    by Yukai Wang, Congfeng Luo, Yi Zhu, Qilin Zhai, Yu Zhan, Weijian Qiu, Yafeng Xu


  • Pathoanatomy and incidence of the posterolateral fractures in bicondylar tibial plateau fractures: a clinical computed tomography-based measurement and the associated biomechanical model simulation

    by Yi Zhu, Severin Meili, Ming-Jie Dong, Qi-Lin Zhai, Lin Yao, Jing-Chao Wang, Cheng-Fang Hu, Hui Sun, Cong-Feng Luo

    The aim of our study is to evaluate the incidence and pathoanatomy of posterolateral fragments and analyze the associated fracture mechanism in bicondylar tibial plateau fractures. From 1.1.2008 to 3.15.2012, all patients suffering bicondylar tibial plateau fractures were identified, scanned and analyzed at the Shanghai Clinical Trauma Center. Furthermore cadaver knees were selected into three groups of 30/60/90 knee flexion to simulate the posterolateral tibial plateau fracture by an impact device. One hundred and sixty-four (44.32 %) bicondylar tibial plateau fractures finally satisfied our requirements. Fifty-three and ninety-four cases were measured eventually in the groups of posterolateral split and depression. The posterolateral articular fragment proportion was 15.43 %. The posterolateral articular fragment angle showed an average of 12.94°. The posterolateral fragment cortical height was on average 2.96 cm. The posterolateral sagittal fragment angle averaged at 72.06°. Ninety-four cases were measured in the posterolateral depression group. The average posterolateral articular depression proportion was 16.74 %. The average posterolateral articular depression height was 2.47 cm. In the biomechanical modeling of such kinds of fracture patterns, posterolateral split fractures in 30° and 60° flexion are significantly more than those in 90° flexion. Posterolateral splits combined with anterolateral depression fractures in 30° flexion are significantly more than those in 90° flexion. The incidence of posterolateral fractures is 44.32 % in bicondylar tibial plateau fractures. The morphology of posterolateral area can be referenced for the surgeon in the future clinical work. The information is also helpful for the design of locking plate and fracture modeling in biomechanical test. In addition, that posterolateral split and posterolateral depression might be caused by different injury mechanisms. Different angles of knee flexion under the axial impact loading are possibly the interpretations for these two fracture patterns.